☆ 4.7 Editorial Material

Durability of High-Frequency 10-kHz Spinal Cord Stimulation for Patients With Painful Diabetic Neuropathy Refractory to Conventional Treatments: 12-Month Results From a Randomized Controlled Trial

DIABETES CARE (2022)

Get Full Text
Add to Collection

Journal

DIABETES CARE
Volume 45, Issue 1, Pages E3-E6

Publisher

AMER DIABETES ASSOC
DOI: 10.2337/dc21-1813

Keywords

-

Categories

Endocrinology & Metabolism

Funding

  1. Nevro Corp.
  2. Medtronic
  3. Neuros Medical
  4. Nevro
  5. ReNeuron
  6. Saluda Medical
  7. Boston Scientific
  8. Vertiflex
  9. Biotronik
  10. Vivex
  11. SPR Therapeutics
  12. Abbott
  13. Neuros
  14. Nalu
  15. Avanos
  16. National Institutes of Health K08 grant [CA228039]
  17. Flowonix
  18. Nuvectra
  19. Mainstay Medical
  20. Allergan
  21. Amgen
  22. DSI
  23. Lilly
  24. Teva
  25. Novartis
  26. Avanos Halyard
  27. Mallinckrodt
  28. Mesoblast

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.